NCT01428076View on ClinicalTrials.gov

Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM)

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Varicose Veins
Interventions
DRUG

Polidocanol Endovenous Microfoam (PEM)

Pharmacokinetic comparison of different doses of drug

Trial Locations (1)

34209

Cardiovascular and Vein Center of Florida, Bradenton

Sponsors

Collaborators (1)

BTG International Inc.
All Listed Sponsors
collaborator

BTG International Inc.

OTHER

lead

Boston Scientific Corporation

INDUSTRY

NCT01428076 - Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM) | Biotech Hunter | Biotech Hunter